Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03730376 · ClinicalTrials.gov registry record · NA

Decision Making in Hypothetical Carpal Tunnel Syndrome

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
488
Enrollment target

NCT03730376: Completed NA study, sponsored by Stanford University.

NCT03730376 is a NA study that has completed, run by Stanford University. The registered enrollment target is 488 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03730376, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
488 participants
Enrollment target

Study Summary

Participants will be presented with a hypothetical scenario of carpal tunnel and asked to make a decision for that case.

Interventions

  • OTHER Cost Information

Trial Details

FieldValue
Enrollment Target 488 participants
Start Date 2018-10-01
Est. Completion 2019-03-01
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03730376

The ClinicalTrials.gov registry entry for NCT03730376 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 488 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cost Information is the first listed.

NCT03730376 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03730376 about?

NCT03730376 is a clinical study titled "Decision Making in Hypothetical Carpal Tunnel Syndrome". Participants will be presented with a hypothetical scenario of carpal tunnel and asked to make a decision for that case.

What is the current status of trial NCT03730376?

This trial is currently completed. It is a NA study. The enrollment target is 488 participants. The study started on 2018-10-01. Estimated completion is 2019-03-01.

What interventions are being tested in trial NCT03730376?

The interventions under investigation include: Cost Information (OTHER).

Who is sponsoring clinical trial NCT03730376?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.